Stephen Phillips

Stephens, Inc. is a full-service investment bank and brokerage firm headquartered in Little Rock, Arkansas. The firm was founded in 1933 and is a subsidiary of Susi Holdings, Inc., which is owned by Stephens Financial Services LLC. Stephens provides comprehensive securities sales and trading services, including customized solutions for clients in North America and abroad.

HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources.

ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX.

410 Medical, Inc. operates as a medical device company. It develops LifeFlow for fluid resuscitation to help patients with life-threatening illnesses such as sepsis. The company was founded by Mark Donald Piehl and Luke Miller Roush in 2013 and is headquartered in Durham, NC.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

The CFO Network LLC provides outsourced accounting services. The American company was founded in 2004. The CEO is Allen Engstrom.

Part of BIOS Capital Management LP, Bios Research LLC is a company that provides investment advice. The company is based in Austin, TX. The company was founded by Aaron G. L. Fletcher.

KPMG Capital Ltd. (KPMG Capital) is a private equity firm founded in 2013. The firm is headquartered in London, United Kingdom.

KPMG is a global organization of independent professional services firms that provide audit, tax, and advisory services. The private company is based in Colombo, Sri Lanka. With over 265,000 employees working in member firms across 143 countries and territories, KPMG is widely recognized as a great place to work and build a career. The Sri Lankan company is committed to community service, inclusion and diversity, and eradicating childhood illiteracy. KPMG operates in 20 countries and territories in the region, with more than 46,000 people in member firms.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Cowtown Angels operates as a financial investment group that supports startups and early stage businesses. The company was founded by Darlene Boudreaux and is headquartered in Fort Worth, TX.

Part of BIOS Capital Management LP, Steelhead Capital Management LLC is an alternative investment manager. The company is based in Fort Worth, TX and was founded in 2008.

Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA.

Part of BIOS Capital Management LP, BIOS Equity Partners LP functions as a private equity firm. The company is based in Texas. The American company was founded by Leslie W. Kreis.

Part of BIOS Capital Management LP, BIOS Equity Partners II LP provides investment services. The company is based in Fort Worth, TX. The company was founded by Leslie W. Kreis.

AyuVis Research, Inc. engages in the provision of pharmaceutical services. The company was founded by Suchi Acharya and Gagan Acharya in 2014 and is headquartered in Fort Worth, TX.

Abilitech Medical, Inc. provides solution to restore function and independence to those affected by neuromuscular conditions. Its product portfolio include Abilitech Assist, Abilitech Medical AbiliGrip, and AbiliGrasp Robotic Assist. The company was founded by Angie Zavoral Conley in 2016 and is headquartered in Eden Prairie, MN.

SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.